Try TabeebPlus fully for 7 days free!

Rheumatology Clinical Calculators & Assessment Tools

Evidence-based rheumatology calculators for rheumatoid arthritis disease activity (DAS28), ankylosing spondylitis activity (BASDAI), systemic lupus erythematosus activity (SLEDAI-2K), ACR/EULAR 2010 RA classification criteria, and functional disability assessment (HAQ-DI).

Why This Matters

Rheumatic diseases affect approximately 1-2% of the global population, with rheumatoid arthritis alone affecting 0.5-1% worldwide. These chronic inflammatory conditions cause significant joint damage, disability, and reduced quality of life if not properly managed. Disease activity assessment is essential for guiding treatment decisions, and validated composite scores are recommended by EULAR, ACR, and other international societies. DAS28 is the most widely used tool for RA activity assessment worldwide, with the EULAR response criteria based on DAS28 change. BASDAI is the gold standard for ankylosing spondylitis activity monitoring. SLEDAI-2K is the most commonly used lupus activity index in clinical trials and practice. The ACR/EULAR 2010 classification criteria enable early RA diagnosis before erosive damage occurs. HAQ-DI is the most widely used functional status measure in rheumatology.

When to Use

Use DAS28 for all RA patients at initial assessment and follow-up to quantify disease activity and guide biologic therapy decisions. Use BASDAI for ankylosing spondylitis patients to assess axial disease activity and determine eligibility for anti-TNF therapy. Use SLEDAI-2K for SLE patients to assess global disease activity at each clinical visit. Use ACR/EULAR 2010 classification when a patient presents with inflammatory arthritis of ≥1 joint to determine if criteria for definite RA are met. Use HAQ-DI to assess functional status in patients with rheumatic diseases for baseline evaluation and monitoring treatment response.

Our rheumatology calculators are developed in accordance with international guidelines including EULAR recommendations for RA management, the Assessment of SpondyloArthritis International Society (ASAS) recommendations for axial spondyloarthritis, ACR guidelines for lupus management, and the original ACR/EULAR 2010 RA classification criteria development and validation studies.

Available Rheumatology Calculators

Clinical Guidelines

  • EULAR Recommendations for the Management of Rheumatoid Arthritis (2023)
  • ACR Guideline for the Treatment of Rheumatoid Arthritis (2021)
  • EULAR/ACR Classification Criteria for SLE (2019)
  • ACR/EULAR 2010 RA Classification Criteria — Aletaha et al. Arthritis Rheum 2010
  • ASAS/EULAR Recommendations for Axial Spondyloarthritis (2022)
Enhance your rheumatology practice with Tabeeb+ clinic management software. Document DAS28, BASDAI, SLEDAI, and HAQ-DI scores in patient records with automated calculation and longitudinal tracking of disease activity and treatment response.

Frequently Asked Questions

DAS28 scores are interpreted as: Remission < 2.6, Low disease activity 2.6-3.2, Moderate disease activity 3.3-5.1, High disease activity > 5.1. The treatment target for most RA patients is remission (DAS28 < 2.6) or at least low disease activity. EULAR response criteria classify patients as good, moderate, or non-responders based on DAS28 improvement from baseline.
A BASDAI score ≥ 4 (out of 10) is typically considered indicative of active disease and is often used as an eligibility criterion for initiating biologic therapy (anti-TNF agents) in ankylosing spondylitis. However, clinical judgment should incorporate additional factors including elevated acute phase reactants, imaging findings, and functional impairment.
SLEDAI-2K allows persistent active disease (rash, alopecia, mucosal ulcers, proteinuria) in the previous 30 days to be scored, whereas the original SLEDAI required these findings to be new or recurrent. SLEDAI-2K also includes ongoing active disease manifestations rather than only new-onset findings, making it more practical for routine clinical use.
The Health Assessment Questionnaire Disability Index (HAQ-DI) is a 20-question instrument assessing functional ability across 8 domains (dressing, arising, eating, walking, hygiene, reach, grip, and activities). Each domain is scored 0-3 (0=without difficulty, 1=with some difficulty, 2=with much difficulty, 3=unable). The total HAQ-DI score is the average of the 8 domain scores, ranging from 0 (no disability) to 3 (completely disabled). A score increase of 0.22-0.25 is considered the minimal clinically important difference.

Integrate these tools into your clinic workflow with Tabeeb+

Try Tabeeb+ for Your Clinic
Medical Disclaimer: This calculator is intended for use by healthcare professionals for educational and clinical decision support purposes only. It is not a substitute for professional clinical judgment.
Call Us
WhatsApp